Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...
With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm”, 'MediPharm Labs” or the 'Company”), a pharmaceutical ...
Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...
Network APIs are transforming manufacturing by turning connectivity into a strategic advantage. By enabling real-time data exchange, automation and secure ...
SSH Manufacturing rose from a humble neighborhood shop into a high-performance global supplier trusted by international ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Several key transitions are currently defining the industry’s direction regarding spicy culinary techniques: 1. The Shift Toward Regional Authenticity Consumers are moving away from generic heat ...
The Maturation of Ethnic Food Safety The international landscape for specialty condiments is currently defined by a move toward “Institutional Trust.” As Japanese culinary traditions continue to ...
JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- As industrial sectors worldwide grapple with increasing ...
PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...